Showing results (41-50 of 90) with videos related to
Sort By:
Pageof 9
Plant Physiology|December 26, 1997
Cellular localization of Arabidopsis xyloglucan endotransglycosylase-related proteins during development and after wind stimulationD M Antosiewicz, M M Purugganan, D H Polisensky, et al.Chest|November 26, 2025
The Mitral Valve and the LungsNatasha M Pradhan, Benjamin S Wessler, Nicholas Hill, et al.Molecular and Cellular Biology|April 25, 2002
Mutational analysis of all conserved basic amino acids in RAG-1 reveals catalytic, step arrest, and joining-deficient mutants in the V(D)J recombinaseLeslie E Huye, Mary M Purugganan, Ming-Ming Jiang, et al.Nature Immunology|April 9, 2002
Distinct and opposite diversifying activities of terminal transferase splice variantsTo-Ha Thai, Mary M Purugganan, David B Roth, et al.JAMA|November 8, 1976
Estrogen-containing oral contraceptive agents. A basis for their thrombogenicityS Wessler, S N Gitel, L S Wan, et al.Haemostasis|January 1, 1979
The thrombogenicity of 6-azouridineS N Gitel, A J Grieco, S Wessler, et al.The Journal of Experimental Medicine|July 21, 1997
Neisseria gonorrhoeae epithelial cell interaction leads to the activation of the transcription factors nuclear factor kappaB and activator protein 1 and the induction of inflammatory cytokinesM Naumann, S Wessler, C Bartsch, et al.Structural Heart : the Journal of the Heart Team|September 9, 2020
Can Clinical Predictive Models Identify Patients Who Should Not Receive TAVR? A Systematic ReviewBenjamin S Wessler, Andrew R Weintraub, James E Udelson, et al.European Journal of Heart Failure|March 29, 2019
Relation between therapy-induced changes in natriuretic peptide levels and long-term therapeutic effects on mortality in patients with heart failure and reduced ejection fractionBenjamin S Wessler, Michael McCauley, Kevin Morine, et al.Nucleic Acids Research|August 1, 1998
V(D)J recombination intermediates and non-standard products in XRCC4-deficient cellsJ O Han, L A Erskine, M M Purugganan, et al.Pageof 9